Parmax Pharma informs about board meeting outcome

12 Nov 2022 Evaluate

Parmax Pharma has informed about Outcome of the Board meeting and approval of Unaudited Financial statements for quarter and half year ended 30th September, 2022.

The above information is a part of company’s filings submitted to BSE.

Parmax Pharma Share Price

29.98 -0.01 (-0.03%)
08-May-2024 11:54 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1520.45
Dr. Reddys Lab 6052.00
Cipla 1392.25
Zydus Lifesciences 1000.15
Lupin 1613.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.